Global Market Study on High Content Screening: APEJ to Witness Fastest Growth Through 2026


High Content Screening  Market
  • Published On : Sep-2018 |
  • Pages : 265 Pages |
  • Format :

This Persistence Market Research report examines the ‘High content screening Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2026’. The primary objective of the report is to offer updates and insights regarding various market opportunities in the global high content screening market.

High content screening is an image based screening technique, which measures the physical and biochemical characteristics in the cells and the organisms. The high content screening techniques have proved to be very useful for the pharmaceutical industry for the characterization of preclinical drugs. Companies are keen on developing integrated system in order to suit varying needs of the end-users Furthermore, increased focus on effective distribution and marketing of such products has increased across the globe. Increasing government support for research and development for drug discovery processes across the globe is expected to drive the growth of High Content Screening (HCS) market during the forecast period. Companies are focused on penetrating untapped market such as Asia Pacific and Latin America, where growth of the biotechnology and biopharmaceutical industry is expected to increase significantly.

 On the basis of product, the market is segmented as cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment are further sub-segmented as High Content Screening (HCS) instruments and flow cytometers. Also, High Content Screening (HCS) instruments are categorised into high-end High Content Screening (HCS), mid-end High Content Screening (HCS) and low-end High Content Screening (HCS) instruments. A detailed analysis has been provided for every segment in terms of market size and volume analysis for High Content Screening (HCS) instruments across the globe.

Primary screening is the isolation of microorganisms which possess interesting characteristics for the industrial applications while the secondary screening is done after the primary screening. The micro-organisms of high importance are then isolated by selective procedures for the secondary screening which is followed further by the Identification of the target its characterization and validation of the molecular mechanisms which is addressed by the target. The target should be efficacious, safe, meet clinical and commercial requirements. Target Validation shows that the molecular target is interacting to the target in a disease process.

To provide an accurate understanding and to assess the opportunities in this market, the high content screening market is categorically split under four sections, namely market analysis by product type, applications, industry and regions. The report analyses the global high content screening market in terms of market value (US$ Mn) and volume.

The report starts with an overview of high content screening and its usage in regions across the globe. In the same section, PMR covers the high content screening performance in terms of revenue. This section includes, PMR analysis of key trends, drivers and restraints from supply-side and demand-side perspective.

The next section of the high content screening report analyses the global high content screening market based on product type and presents the forecast in terms of value for the next 08 years. The product types covered in the report include:

  • Cell Imaging & Analysis
  • consumables
  • Software
  • Services

The next section of the report analyses the global high content screening market based on Applications and presents the forecast in terms value for the next 08 years. The Applications covered in the report include:

  • Primary & Secondary Screening
  • Target Identification & Validation
  • Toxicity Studies
  • Compound Profiling
  • Others

The next section of the report analyses the global high content screening market based on industry and presents the forecast in terms value for the next 08 years. The industry covered in the report include:

  • Pharmaceutical & Healthcare
  • Biotechnology
  • Educational Institutions
  • Independent CRO
  • Government Organizations
  • Others

The next section of the report analyses the global high content screening market based on regions and presents the forecast in terms of value for the next 08 years. The regions covered in the report include:

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

To arrive at market size, the report considers company share analysis for the majority of the companies, which includes approximatly 60% share from the geographies. The forecast presented here assesses the total revenue of the hearing implant market. Given the characteristics of the market, we have triangulated the outcome based on different analysis such as supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities, rather than rationalizing them after the forecast has been completed.

In addition, we have taken into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the market.

As previously highlighted, the market for high content screening is split into various sub-segments based on region, product type, applications and industry. All these sub-segments or categories have been analysed to understand individual segments’ relative contribution to the growth. This detailed level of information is important for identification of the many key trends in the hearing implant market.

Also, another key feature of this report is the analysis of high content screening by regions, product type, applications and industry. The revenue forecast in terms of absolute dollar value is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective.

Furthermore, Persistence market research has developed market attractiveness index for all four segments – regional, product type, applications type and industry type segments. This index helps in identifying the real opportunities available in the market.

In the final section of the report, the high content screening market landscape is included to provide report audiences with a dashboard view, based on categories of providers across the market, presence in high content screening market portfolio and key differentiators.

Examples of some of the key players operating in the global hearing implants market include Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation and  Sysmex Corporation

High content screening market: Introduction

High content screening is an image based screening technique, which measures the physical and biochemical characteristics in the cells and the organisms. The high content screening includes the software for image capturing, its evaluation and data storage. High Content Screening (HCS), which is significantly transforming global businesses and enterprises. New product launches is resulting in product assortment and thus, increased installation of High Content Screening (HCS) instruments. This is expected to bolster growth of the High Content Screening (HCS) market over. Owing to enhanced toxicity studies, demand for novel technologies in cell analysis is increasing rapidly across the globe. Instruments with enhanced cell imaging and analysis are preferred for early as well as later stages of the drug discovery process. This is expected to fuel the demand for High Content Screening (HCS) instruments in the near future. Also, increasing government support for life sciences research and increasing progress towards establishment of innovation and research-based biotechnology industries, primarily in countries such as China and India, is expected to contribute towards increased growth rate during the forecast period.

High content screening Market: Value Forecast

The global high content screening market was valued at US$ 1,321.9 Mn in 2017 and is expected to expand at a CAGR of 5.0% over the forecast period (2018–2026).

High content screening Market: Dynamics

The growth of the global high content screening market is mainly driven by Extensive Research and Development in innovation and drug discovery Increasing neurodegenerative diseases such as cancer, Alzheimer and Parkinson’s across the globe is expected to drive demand for advances healthcare services. This has led international players across the globe to invest considerably on research and development in order to introduce innovative products to cater to the demand across the supply chain in the near future. Companies are developing automated solutions such as instruments with advanced visualization capability in line with enhanced software platform to sustain in a market that is being influenced by changing demographics on a global scale. Owing to few efficient HCS systems manufacturers in this market, companies are focusing on cost optimization in order to increase productivity. Although, prices of High Content Screening (HCS) instruments are higher as compared to flow cytometers, availability of these instruments across educational institutions is expected to increase during the forecast period. In order to offer comprehensive offerings to lab services, manufactures need to develop such instruments. Also, there has been an increase in development of automated systems to analyze cell separation and scalability. Demand for efficient purification protocols for therapeutic cells is expected to fuel demand for high-end screening system in the upcoming years

High content screening Market: Key Regions

The global high content screening market has been segmented on the basis of regions into North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan (APEJ), Japan and Middle East & Africa (MEA). In terms of revenue, North America is projected to be the dominant regional market for high content screening throughout the forecast period as manufacturers in the region are developing products that have the potential to analyze the live cells, its imaging and further target identification and validation of the drugs. Moreover the device helps in analyzing the mutations and the changes in the RNA and toxicity studies which will improve in efficiency and development of the drugs. APECJ, Japan and China are expected to witness significant growth during the forecast period as numerous research and development activities are been carried out by the manufactures to improve the cell analyzers and flow cytomeres in the high content screening market. The U.S. is expected to be the dominant market in North America due to a advancement in the technologies. The U.S., Germany, the U.K. and Australia contribute a major share in the global high content screening market. 

high content screening industry

High content screening Market: Key Players

Since, the market for High Content Screening (HCS) instruments is consolidated in nature, major players across the globe are focused on developing new product offerings across various products, which includes instruments, consumables, software and services for cell analysis. This ensures sustainability in the long run and restricts new entrants from entering the market. The global High Content Screening (HCS) market competitive landscape includes Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation and  Sysmex Corporation

Company Profiles

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Merck Millipore Corporation
  • Danaher Corporation (Molecular Devices)
  • Yokogawa Electric Corporation
  • Sysmex Corporation
  • Others.
Back To Top